Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Junutula JR"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maecker H; Aarvik Therapeutics, Inc, Hayward, CA, USA., Jonnalagadda V; Aarvik Therapeutics, Inc, Hayward, CA, USA., Bhakta S; Aarvik Therapeutics, Inc, Hayward, CA, USA., Jammalamadaka V; Aarvik Therapeutics, Inc, Hayward, CA, USA., Junutula JR; Aarvik Therapeutics, Inc, Hayward, CA, USA.
Publikováno v:
MAbs [MAbs] 2023 Jan-Dec; Vol. 15 (1), pp. 2229101.
Autor:
Suryamohan K; Research and Development Department, MedGenome Inc, Foster City, CA, USA., Diwanji D; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Stawiski EW; Research and Development Department, MedGenome Inc, Foster City, CA, USA., Gupta R; MedGenome Labs Ltd., Bangalore, Karnataka, India., Miersch S; Department of Molecular Genetics, and the Terrence Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada., Liu J; ModMab Therapeutics, Foster City, CA, USA., Chen C; Department of Molecular Genetics, and the Terrence Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada., Jiang YP; ModMab Therapeutics, Foster City, CA, USA., Fellouse FA; ModMab Therapeutics, Accelerator for Donnelly Collaboration, University of Toronto, Toronto, ON, Canada., Sathirapongsasuti JF; Research and Development Department, MedGenome Inc, Foster City, CA, USA., Albers PK; Wellcome Sanger Institute, Cambridge, UK., Deepak T; MedGenome Labs Ltd., Bangalore, Karnataka, India., Saberianfar R; ModMab Therapeutics, Accelerator for Donnelly Collaboration, University of Toronto, Toronto, ON, Canada., Ratan A; Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA., Washburn G; Research and Development Department, MedGenome Inc, Foster City, CA, USA., Mis M; Research and Development Department, MedGenome Inc, Foster City, CA, USA., Santhosh D; ModMab Therapeutics, Foster City, CA, USA., Somasekar S; Midwestern University, Glendale, AZ, USA., Hiranjith GH; Research and Development Department, MedGenome Inc, Foster City, CA, USA., Vargas D; Research and Development Department, MedGenome Inc, Foster City, CA, USA., Mohan S; Department of Molecular Biology, SciGenom Labs Pvt Ltd, Kochi, Kerala, India., Phalke S; Department of Molecular Biology, SciGenom Labs Pvt Ltd, Kochi, Kerala, India., Kuriakose B; AgriGenome Labs Private Ltd, Kochi, Kerala, India., Antony A; Department of Molecular Biology, SciGenom Labs Pvt Ltd, Kochi, Kerala, India., Ustav M Jr; Department of Molecular Genetics, and the Terrence Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada., Schuster SC; Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, Singapore., Sidhu S; Department of Molecular Genetics, and the Terrence Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada., Junutula JR; ModMab Therapeutics, Foster City, CA, USA., Jura N; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA. natalia.jura@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA. natalia.jura@ucsf.edu., Seshagiri S; ModMab Therapeutics, Foster City, CA, USA. sekar@sgrf.org.; SciGenom Research Foundation, Bangalore, Karnataka, India. sekar@sgrf.org.
Publikováno v:
Communications biology [Commun Biol] 2021 Apr 12; Vol. 4 (1), pp. 475. Date of Electronic Publication: 2021 Apr 12.
Autor:
Bhakta S, Crocker LM, Chen Y, Hazen M, Schutten MM, Li D, Kuijl C, Ohri R, Zhong F, Poon KA, Go MAT, Cheng E, Piskol R, Firestein R, Fourie-O'Donohue A, Kozak KR, Raab H, Hongo JA, Sampath D, Dennis MS, Scheller RH, Polakis P, Junutula JR
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2019 Nov; Vol. 18 (11), pp. 2182.
Autor:
Jiang YP; Cellerant Therapeutics Inc, San Carlos, CA; and., Liu BY; Cellerant Therapeutics Inc, San Carlos, CA; and., Zheng Q; Cellerant Therapeutics Inc, San Carlos, CA; and., Panuganti S; Cellerant Therapeutics Inc, San Carlos, CA; and., Chen R; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH., Zhu J; Cellerant Therapeutics Inc, San Carlos, CA; and., Mishra M; Cellerant Therapeutics Inc, San Carlos, CA; and., Huang J; Cellerant Therapeutics Inc, San Carlos, CA; and., Dao-Pick T; Cellerant Therapeutics Inc, San Carlos, CA; and., Roy S; Cellerant Therapeutics Inc, San Carlos, CA; and., Zhao X; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH., Lin J; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH., Banik G; Cellerant Therapeutics Inc, San Carlos, CA; and., Hsi ED; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH., Mandalam R; Cellerant Therapeutics Inc, San Carlos, CA; and., Junutula JR; Cellerant Therapeutics Inc, San Carlos, CA; and.
Publikováno v:
Blood advances [Blood Adv] 2018 Jul 24; Vol. 2 (14), pp. 1738-1749.
Autor:
Bhakta S; Genentech, Inc., 1 DNA Way, South San Francisco, California. sbhakta@gene.com jagathjr@gmail.com., Crocker LM; Genentech, Inc., 1 DNA Way, South San Francisco, California., Chen Y; Genentech, Inc., 1 DNA Way, South San Francisco, California., Hazen M; Genentech, Inc., 1 DNA Way, South San Francisco, California., Schutten MM; Genentech, Inc., 1 DNA Way, South San Francisco, California., Li D; Genentech, Inc., 1 DNA Way, South San Francisco, California., Kuijl C; Genentech, Inc., 1 DNA Way, South San Francisco, California., Ohri R; Genentech, Inc., 1 DNA Way, South San Francisco, California., Zhong F; Genentech, Inc., 1 DNA Way, South San Francisco, California., Poon KA; Genentech, Inc., 1 DNA Way, South San Francisco, California., Go MAT; Genentech, Inc., 1 DNA Way, South San Francisco, California., Cheng E; Genentech, Inc., 1 DNA Way, South San Francisco, California., Piskol R; Genentech, Inc., 1 DNA Way, South San Francisco, California., Firestein R; Genentech, Inc., 1 DNA Way, South San Francisco, California., Fourie-O'Donohue A; Genentech, Inc., 1 DNA Way, South San Francisco, California., Kozak KR; Genentech, Inc., 1 DNA Way, South San Francisco, California., Raab H; Genentech, Inc., 1 DNA Way, South San Francisco, California., Hongo JA; Genentech, Inc., 1 DNA Way, South San Francisco, California., Sampath D; Genentech, Inc., 1 DNA Way, South San Francisco, California., Dennis MS; Genentech, Inc., 1 DNA Way, South San Francisco, California., Scheller RH; Genentech, Inc., 1 DNA Way, South San Francisco, California., Polakis P; Genentech, Inc., 1 DNA Way, South San Francisco, California., Junutula JR; Genentech, Inc., 1 DNA Way, South San Francisco, California. sbhakta@gene.com jagathjr@gmail.com.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2018 Mar; Vol. 17 (3), pp. 638-649. Date of Electronic Publication: 2017 Dec 27.